Sereneuro Therapeutics, Inc.
Baltimore, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| SN102: a novel gene therapy for trigeminal neuralgia pain | National Institute of Dental and Craniofacial Research (NIH) | $338,115 |
Quick answers
Is Sereneuro Therapeutics, Inc. registered in SAM.gov?
Yes. Sereneuro Therapeutics, Inc.'s SAM.gov registration is active through September 17, 2027.
What is Sereneuro Therapeutics, Inc.'s CAGE code?
Sereneuro Therapeutics, Inc.'s CAGE code is 08G12, and its Unique Entity ID (UEI) is Y89DBCYUCMH1.
What is Sereneuro Therapeutics, Inc.'s most recent federal award?
Sereneuro Therapeutics, Inc.'s most recent federal grant award is SN102: a novel gene therapy for trigeminal neuralgia pain (R43DE035747), from National Institute of Dental and Craniofacial Research (NIH), on September 23, 2026.
On GovTribe
See Sereneuro Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors